Genetic predisposition and renal allograft failure: Implication of non-HLA genetic variants

Molecular Diagnosis and Therapy

Volumn 10, Issue 4, 2006, Pages 205-219

  Khan, Faisal ^a   Agrawal, Swati ^b   Agrawal, Suraksha ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CYCLOSPORIN A; CYTOKINE; CYTOKINE RECEPTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR; GAMMA INTERFERON; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HOMOCYSTEINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LEUKOCYTE ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTERY THROMBOSIS; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; GRAFT FAILURE; HUMAN; HYPERTENSION; IMMUNE RESPONSE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; TH1 CELL; TH2 CELL; TREATMENT OUTCOME; VEIN THROMBOSIS;

EID: 33747121589     PISSN: 11771062     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03256459     Document Type: Review

References (121)

1. Hernandez-Fuentes MP, Lechler RI. Chronic graft loss: immunological and non-immunological factors. Contrib Nephrol 2005; 146: 54-64
2. Poole KL, Gibbs PJ, Evans PR, et al. Influence of patient and donor cytokine genotypes on renal allograft rejection: evidence from a single centre study. Transpl Immunol 2001; 8 (4): 259-65
3. Gjertson DW. Look-up survival tables for living-donor renal transplants: OPTN/UNOS data 1995-2002. Clin Transpl 2003: 337-86
4. Magee CC, Pascual M. Update in renal transplantation. Arch Intern Med 2004; 164 (13): 1373-88
5. McDaniel DO, Barber WH, Nguyan C, et al. Combined analysis of cytokine genotype polymorphism and the level of expression with allograft function in African-American renal transplant patients. Transpl Immunol 2003; 11 (1): 107-19
6. Stepkowski SM. Immunobiology of allgraft rejection. In: Kahan BD, Ponticielli C, editors. Principles and practice of renal transplantation. Malden (MA): Blackwell Science Inc., 2000: 41-87
7. Cardarelli F, Saidman S, Theruvath T, et al. The problem of late allograft loss in kidney transplantation. Minerva Urol Nefrol 2003; 55 (1): 1-11
8. Beige J, Kreutz R, Tscherkaschina I, et al. Matrix analysis for the dissection of interactions of G-protein beta3 subunit C825T genotype, allograft function, and posttransplant hypertension in kidney transplantation. Am J Kidney Dis 2002; 40 (6): 1319-24
9. Suthanthiran M. The importance of genetic polymorphisms in renal transplantation. Curr Opin Urol 2000; 10 (2): 71-5
10. Sharma AM, Beige J, Distler A. Role of genetic variants of the renin-angiotensin system in chronic renal allograft injury. Kidney Int 1998; 53 (6): 1461-5
11. George S, Turner D, Reynard M, et al. Significance of cytokine gene polymorphism in renal transplantation. Transplant Proc 2001; 33 (1-2): 483-4
12. Hutchinson IV, Pravica V, Perrey C, et al. Cytokine gene polymorphisms and relevance to forms of rejection. Transplant Proc 1999; 31 (1-2): 734-6
13. Hutchinson IV, Turner D, Sankaran D, et al. Cytokine genotypes in allograft rejection: guidelines for immunosuppression. Transplant Proc 1998; 30 (8): 3991-2
14. Hahn AB, Kasten-Jolly JC, Constantino DM, et al. TNF-alpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R: effects on renal allograft outcome. Transplantation 2001; 72 (4): 660-5
15. Muller-Steinhardt M, Hartel C, Muller B, et al. The interleukin-6 -174promoter polymorphism is associated with long-term kidney allograft survival. Kidney Int 2002; 62 (5): 1824-7
16. Rifle G, Mousson C, Martin L, et al. Donor-specific antibodies in allograft rejection: clinical and experimental data. Transplantation 2005; 79 (3 Suppl.): S14-8
17. Kamoun M. Cellular and molecular parameters in human renal allograft rejection. Clin Biochem 2001; 34 (1): 29-34
18. Delaney NL, Esquenazi V, Lucas DP, et al. TNF-alpha, TGF-beta, IL-10, IL-6, and INF-gamma alleles among African Americans and Cuban Americans. Report of the ASHI Minority Workshops: Part IV. Hum Immunol 2004 Dec; 65 (12): 1413-9
19. Pirenne J, Kitade H, Kawai M, et al. Regulatory cells, TH1/TH2 unbalance, and antibody-induced chronic rejection in operational tolerance induced by donor-specific blood transfusion. Transplantation 2005; 79 (3 Suppl.): S25-7
20. Kitade H, Kawai M, Koshiba T, et al. Early accumulation of interferon-gamma in grafts tolerized by donor-specific blood transfusion: friend or enemy? Transplantation 2004; 79: 456-9
21. Sayegh MH, Turka LA. The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998; 338 (25): 1813-21
22. Harlan DM, Kirk AD. The future of organ and tissue transplantation: can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection? JAMA 1999; 282 (11): 1076-82
23. Hutchinson IV. The role of transforming growth factor-beta in transplant rejection. Transplant Proc 1999; 31 (7A): 9S-13S
24. Kruger B, Schroppel B, Ashkan R, et al. A Monocyte chemoattractant protein-1 (MCP-1) polymorphism and outcome after renal transplantation. J Am Soc Nephrol 2002; 13 (10): 2585-9
25. Lalor PF, Adams DH. Lymphocyte homing to allografts. Transplantation 2000; 70 (8): 1131-9
26. Shahbazi M, Fryer AA, Pravica V, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 2002; 13 (1): 260-4
27. Cox ED, Hoffmann SC, DiMercurio BS, et al. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin2 and interleukin-6. Transplantation 2001; 72 (4): 720-6
28. University of Bristol. Cytokine gene polymorphism in human disease: online databases [online]. Available from URL: http://www.bris.ac.uk/Depts/ PathAndMicro/services/GAI/cytokine4.htm [Accessed 2006 Jun 16]
29. Cartwright N, Demaine A, Jahromi M, et al. A study of cytokine protein secretion, frequencies of cytokine expressing cells and IFN-G gene polymorphisms in normal individuals. Transplantation 1999; 68 (10): 1546-52
30. Pravica V, Asderakis A, Perrey C, et al. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999; 26 (1): 1-3
31. Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24 (1): 1-8
32. Maurer M, Kruse N, Giess R, et al. Genetic variation at position -1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis. J Neuroimmunol 2000; 104 (1): 98-100
33. Crawley E, Kay R, Sillibourne J, et al. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42 (6): 1101-8
34. Eskdale J, Gallagher G, Verweij CL, et al. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A 1998; 95 (16): 9465-70
35. Tountas NA, Casini-Raggi V, Yang H, et al. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology 1999; 117 (4): 806-13
36. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998; 28 (8): 2598-602
37. Pociot F, Molvig J, Wogensen L, et al. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992; 22 (6): 396-402
38. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102 (7): 1369-76
39. Linker-Israeli M, Wallace DJ, Prehn J, et al. Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression. Genes Immun 1999; 1 (1): 45-52
40. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275 (24): 18138-44
41. Awad MR, El-Gamel A, Hasleton P, et al. Polymorphism in transforming growth factor-beta 1 gene and its correlation to TGF-beta 1 production, allograft fibrosis and fibrotic lung diseases [abstract]. Eur J Immunogenet 1998; 25: 70
42. Higuchi T, Seki N, Kamizono S, et al. Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998; 51 (6): 605-12
43. Obayashi H, Nakamura N, Fukui M, et al. Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitus. Hum Immunol 1999; 60 (10): 974-8
44. Grove J, Daly AK, Bassendine MF, et al. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997; 26 (1): 143-6
45. Uglialoro AM, Turbay D, Pesavento PA, et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 1998; 52 (4): 359-67
46. Turner DM, Grant SC, Lamb WR, et al. A genetic marker of high TNF-alpha production in heart transplant recipients. Transplantation 1995; 60 (10): 1113-7
47. Kroeger KM, Steer JH, Joyce DA, et al. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 2000; 12 (2): 110-9
48. Asderakis A, Sankaran D, Dyer P, et al. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation. Transplantation 2001; 71 (5): 674-7
49. Hoffmann S, Park J, Jacobson LM, et al. Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. Kidney Int 2004; 66 (4): 1686-93
50. Pelletier R, Pravica V, Perrey C, et al. Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation. Transplantation 2000; 70 (4): 674-80
51. Hutchinson IV, Pravica V, Hajeer A, et al. Identification of high and low responders to allografts. Rev Immunogenet 1999; 1 (3): 323-33
52. Mytilineos J, Laux G, Opelz G. Relevance of IL10, TGFbeta1, TNFalpha, and IL4Ralpha gene polymorphisms in kidney transplantation: a collaborative transplant study report. Am J Transplant 2004; 4 (10): 1684-90
53. Alakulppi NS, Kyllonen LE, Jantti VT, et al. Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation. Transplantation 2004; 78 (10): 1422-8
54. Bathgate AJ, Pravica V, Perrey C, et al. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation 2000; 56: 890-6
55. Abdallah AN, Cucchi-Mouillot P, Biteau N, et al. Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection. Eur J Immunogenet 1999; 26 (4): 249-55
56. Yang L, Liu Y. Cytokine gene polymorphisms predict acute rejection following renal transplantation. International Congress series 2003; 1255: 99-100
57. Marshall SE, McLaren AJ, McKinney EF, et al. Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation 2001; 71 (3): 469-76
58. Sankaran D, Asderakis A, Ashraf S, et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 1999; 56 (1): 281-8
59. Poli F, Boschiero L, Giannoni F, et al. Tumour necrosis factor-alpha gene polymorphism: implications in kidney transplantation. Cytokine 2000; 12 (12): 1778-83
60. Marshall SE, McLaren AJ, Haldar NA, et al. The impact of recipient cytokine genotype on acute rejection after renal transplantation. Transplantation 2000; 70 (10): 1485-91
61. Guasch JF, Bertina RM, Reitsma PH. Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informatively. Cytokine 1996; 8 (8): 598-602
62. Hershey GK, Friedrich MF, Esswein LA, et al. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 1997; 337 (24): 1720-5
63. Ozden H, Kabay B, Guven G, et al. Interleukin-10 gene transfection of donor pancreas grafts protects against rejection after heterotopic pancreas transplantation in a rat model. Eur Surg Res 2005 Jul-Aug; 37 (4): 220-7
64. Xing Z, Gauldie J, Cox G, et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101 (2): 311-20
65. Muller-Steinhardt M, Fricke L, Muller B, et al. Cooperative influence of the interleukin-6 promoter polymorphisms -597, -572 and -174 on long-term kidney allograft survival. Am J Transplant 2004; 4 (3): 402-6
66. Rollins BJ. Chemokines. Blood 1997; 90 (3): 909-28
67. Stievano L, Piovan E, Amadori A. C and CX3C chemokines: cell sources and physiopathological implications. Crit Rev Immunol 2004; 24 (3): 205-28
68. DeVries ME, Hosiawa KA, Cameron CM, et al. The role of chemokines and chemokine receptors in alloantigen-independent and alloantigen-dependent transplantation injury. Semin Immunol 2003; 15 (1): 33-48
69. Abdi R, Tran TB, Sahagun-Ruiz A, et al. Chemokine receptor polymorphism and risk of acute rejection in human renal transplantation. J Am Soc Nephrol 2002; 13 (3): 754-8
70. Hancock WW. Chemokines and transplant immunobiology. J Am Soc Nephrol 2002; 13 (3): 821-4
71. Fischereder M, Luckow B, Hocher B, et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 2001; 357 (9270): 1758-61
72. McDermott DH, Halcox JP, Schenke WH, et al. Association between polymortion phism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis. Circ Res 2001; 89 (5): 401-7
73. Grandaliano G, Gesualdo L, Ranieri E, et al. Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection. Transplantation 1997 Feb 15; 63 (3): 414-20
74. Huser N, Tertilt C, Gerauer K, et al. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model. Eur J Immunol 2005; 35 (1): 128-38
75. McLaren AJ, Marshall SE, Haldar NA, et al. Adhesion molecule polymorphisms in chronic renal allograft failure. Kidney Int 1999; 55 (5): 1977-82
76. Pawlik A, Florczak M, Bak L, et al. The correlation between FcgammaRIIA polymorphism and renal allograft survival. Transplant Proc 2002; 34 (8): 3138-9
77. Salmon JE, Edberg JC, Brogle NL, et al. Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB: independent mechanisms for differences in human phagocyte function. J Clin Invest 1992; 89 (4): 1274-81
78. Densem CG, Hutchinson IV, Cooper A, et al. Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation. J Heart Lung Transplant 2000; 19 (6): 551-6
79. Awad MR, El-Gamel A, Hasleton P, et al. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998; 66 (8): 1014-20
80. Ochsner S, Guo Z, Binswanger U, et al. TGF-beta 1 gene expression in stable renal transplant recipients: influence of TGF-beta 1 gene polymorphism and immunosuppression. Transplant Proc 2002; 34 (7): 2901-3
81. Melk A, Henne T, Kollmar T, et al. Cytokine single nucleotide polymorphisms and intrarenal gene expression in chronic allograft nephropathy in children. Kidney Int 2003; 64 (1): 314-20
82. Park JY, Park MH, Park H, et al. TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans. Tissue Antigens 2004; 64 (6): 660-6
83. Babel N, Cherepnev G, Kowalenko A, et al. Non-immunologic complications and gene polymorphisms of immuno-regulatory cytokines in long-term renal transplants. Kidney Int 2004; 66 (1): 428-32
84. Lemos FB, Mol WM, Roodnat JI, et al. The beneficial effects of recipient-derived vascular endothelial growth factor on graft survival after kidney transplantation. Transplantation 2005 May 15; 79 (9): 1221-5
85. Slavcheva E, Albanis E, Jiao Q, et al. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection. Transplantation 2001; 72 (5): 935-40
86. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int 1998; 53 (1): 217-22
87. Yildiz A, Yazici H, Cine N, et al. The effect of angiotensin converting enzyme gene polymorphism on chronic allograft dysfunction in living donor renal transplant recipients. Clin Transplant 2002; 16 (3): 173-9
88. Viklicky O, Hubacek JA, Pitha J, et al. ACE gene polymorphism and long-term renal graft function. Clin Biochem 2001; 34 (1): 87-90
89. Smit-van Oosten A, Stegeman CA, van Goor H. RAS blockade in experimental renal transplantation: benefits and limitations. Curr Drug Targets Cardiovasc Haematol Disord 2003; 3 (1): 73-9
90. Redon J, Chaves FJ, Liao Y, et al. Influence of the I/D polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension. Hypertension 2000; 35: 490-5
91. van Essen GG, Rensma PL, de Zeew D, et al. Association between angiotensin converting enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996; 347: 94-5
92. Parving HH, Jacobson P, Tarnow L, et al. Effect of deletion polymorphism of angiotensin converting enzyme on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational followup study. BMJ 1996; 313: 591-4
93. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/deletion polymorphism in the angiotensin I- converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6
94. Mitch WE. Is the inherited ACE genotype a trump or a joker? J Clin Invest 1995; 96: 2100-1
95. Burg M, Menne J, Ostendorf T, et al. Gene-polymorphisms of angiotensin converting enzyme and endothelial nitric oxide synthase in patients with primary glomerulonephritis. Clin Nephrol 1997; 48: 205-11
96. Barocci S, Ginevri F, Valente U, et al. Correlation between angiotensin-converting enzyme gene insertion/deletion polymorphism and kidney graft long-term outcome in pediatric recipients: a single-center analysis. Transplantation 1999; 67 (4): 534-8
97. Kabat-Koperska J, Baskiewicz-Masiuk M, Safranow K, et al. The influence of Angiotensin-converting enzyme gene of donor and recipient on the function of transplanted kidney. Transplant Proc 2005; 37 (2): 755-9
98. Pereira AC, Mota GA, Bensenor I, et al. Effect of race, genetic population structure, and genetic models in two-locus association studies: clustering of functional renin-angiotensin system gene variants in hypertension association studies. Braz J Med Biol Res 2001 Nov; 34 (11): 1421-8
99. Akcay A, Sezer S, Ozdemir FN, et al. Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction. Transplantation 2004; 78 (6): 892-8
100. Ozdemir FN, Basaran O, Ozdemir BH, et al. Angiotensin-converting enzyme and endothelial constitutive nitric oxide synthase polymorphisms in Turkish renal transplant population and possible influence on renal artery atherosclerosis and graft survival. Transplant Proc 2005; 37 (7): 2929-32
101. Siffert W, Rosskopf D, Siffert G, et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998; 18 (1): 45-8
102. Beige J, Hohenbleicher H, Distler A, et al. G-Protein beta3 subunit C825T variant and ambulatory blood pressure in essential hypertension. Hypertension 1999; 33 (4): 1049-51
103. Viklicky O, Hubacek JA, Vitko S, et al. G-protein beta-3-subunit and eNOS gene polymorphism in transplant recipients with long-term renal graft function. Kidney Blood Press Res 2002; 25 (4): 245-9
104. Cossu M, Carru C, Pes GM, et al. Plasma homocysteine levels and C677T MTHFR gene polymorphism in stable renal graft recipients. Transplant Proc 2001; 33 (1-2): 1156-8
105. Fodinger M, Horl WH, Sunder-Plassmann G. Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol 2000; 13 (1): 20-33
106. Fodinger M, Wolfl G, Fischer G, et al. Effect of MTHFR 677C>T on plasma total homocysteine levels in renal graft recipients. Kidney Int 1999; 55 (3): 1072-80
107. Viklicky O, Hubacek JA, Kvasnicka J, et al. Association of methylenetetrahydrofolate reductase T677 allele with early development of chronic allograft nephropathy. Clin Biochem 2004; 37 (10): 919-24
108. Winkelmayer WC, Huber A, Wagner OF, et al. Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and vitamin B in kidney transplant recipients. Kidney Int 2005 May; 67 (5): 1980-5
109. Gruber SA, Chavers B, Payne WD, et al. Allograft renal vascular thrombosis: lack of increase with cyclosporine immunosuppression. Transplantation 1989; 47 (3): 475-8
110. Irish A. Hypercoagulability in renal transplant recipients: identifying patients at risk of renal allograft thrombosis and evaluating strategies for prevention. Am J Cardiovasc Drugs 2004; 4 (3): 139-49
111. Heidenreich S, Nowak-Gottl U, August C. Hypercoagulable state and graft rejection: is there a link? Nephrol Dial Transplant 1999; 14 (10): 2293-6
112. Fischereder M, Gohring P, Schneeberger H, et al. Early loss of renal transplants in patients with thrombophilia. Transplantation 1998; 65 (7): 936-9
113. Irish AB, Green FR, Gray DW, et al. The factor V Leiden (R506Q) mutation and risk of thrombosis in renal transplant recipients. Transplantation 1997; 64 (4): 604-7
114. McLeod HL, Siva C. The thiopurine S-methyltransferase gene locus: implications for clinical pharmacogenomics. Pharmacogenomics 2002; 3 (1): 89-98
115. Kuzuya T, Kobayashi T, Moriyama N, et al. Amlodipine, but not MDR1 polymorphisms, alters the pharmacokinetics of cyclosporine A in Japanese kidney transplant recipients. Transplantation 2003; 76 (5): 865-8
116. Anglicheau D, Verstuyft C, Laurent-Puig P, et al. Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients. J Am Soc Nephrol 2003; 14 (7): 1889-96
117. Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 2000; 97 (7): 3473-8
118. Hitzl M, Drescher S, van der Kuip H, et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics 2001; 11 (4): 293-8
119. Kim RB, Leake BF, Choo EF, et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 2001; 70 (2): 189-99
120. Perrey C, Turner SJ, Pravica V, et al. ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms. Transpl Immunol 1999 Jun; 7 (2): 127-8
121. Khan F, Agarwal A, Agrawal S. Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant 2004; 34 (1): 1-12